B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Alvespimycin

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alvespimycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

19-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin
5 shared targets · score 40.5
bdb
2 shared targets
onalespib
2 shared targets
triolimus
5 shared targets · score 43.4
luminespib
2 shared targets
biib021
2 shared targets
snx
2 shared targets
ganetespib
2 shared targets
pu
2 shared targets
Novobiocin
2 shared targets · score 43
Loading evidence profile...

This evidence profile for Alvespimycin is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.